Bath & Body Works (NYSE:BBWI) Price Target Raised to $42.00

Bath & Body Works (NYSE:BBWI) had its price objective lifted by analysts at TD Cowen from $40.00 to $42.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s target price points to a potential upside of 19.05% from the stock’s current price.

A number of other analysts also recently commented on BBWI. Robert W. Baird decreased their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. JPMorgan Chase & Co. raised their target price on Bath & Body Works from $35.00 to $39.00 and gave the stock a “neutral” rating in a research report on Tuesday. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Telsey Advisory Group reissued an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research note on Monday. Finally, The Goldman Sachs Group reduced their target price on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $0.50 on Tuesday, hitting $35.28. The company had a trading volume of 3,136,495 shares, compared to its average volume of 3,958,885. The firm has a market cap of $7.73 billion, a P/E ratio of 8.54, a P/E/G ratio of 0.98 and a beta of 1.79. The stock’s 50-day moving average is $30.69 and its two-hundred day moving average is $35.74. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. Equities research analysts predict that Bath & Body Works will post 3.18 EPS for the current year.

Insider Buying and Selling

In other news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. First Community Trust NA purchased a new stake in Bath & Body Works during the second quarter worth about $30,000. True Wealth Design LLC raised its position in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after buying an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works in the third quarter valued at approximately $39,000. Finally, TD Private Client Wealth LLC increased its position in Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.